Literature DB >> 6183450

Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments.

B Dietzschold, T J Wiktor, R Macfarlan, A Varrichio.   

Abstract

After rabies virus glycoprotein was treated with CNBr, the peptide mixture was fractionated by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis. CNBr-cleaved peptide fragments were resolved into seven peptide bands under reducing conditions and six peptide bands under nonreducing conditions. The isolated nonreduced polypeptides were further analyzed by electrophoresis under reducing conditions. The N-terminal amino acid sequences were determined for the peptides in each of the isolated bands. The sequence data identified eight CNBr peptides and allowed the peptide fragments to be ordered within the deduced amino acid sequence of the glycoprotein. Analysis of the nonreduced CNBr peptides revealed two conformations of the glycoprotein. Two CNBr peptide fragments were specifically immunoprecipitated with a hyperimmune anti-rabies glycoprotein serum. These two and one other CNBr peptide induced the production of rabies virus-neutralizing antibodies, indicating the existence of at least three distinct antigenic sites on the rabies virus glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183450      PMCID: PMC256303     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Oligosaccharides of the glycoprotein of rabies virus.

Authors:  B Dietzschold
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

2.  A new, improved technique for automated sequencing of non-polar peptides.

Authors:  J A Foster; E Bruenger; C L Hu; K Albertson; C Franzblau
Journal:  Biochem Biophys Res Commun       Date:  1973-07-02       Impact factor: 3.575

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Partial primary structure of bacteriorhodopsin: sequencing methods for membrane proteins.

Authors:  G E Gerber; R J Anderegg; W C Herlihy; C P Gray; K Biemann; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Induction and biological properties of defective interfering particles of rabies virus.

Authors:  T J Wiktor; B Dietzschold; R N Leamnson; H Koprowski
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

7.  Antigenic determinants of influenza virus hemagglutinin. I. Cyanogen bromide peptides derived from A/MEMPHIS/72 hemagglutinin possess antigenic activity.

Authors:  D C Jackson; R J Russell; C W Ward; T A Dopheide
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

8.  A rapid tissue culture test for determining rabies neutralizing antibody.

Authors:  J S Smith; P A Yager; G M Baer
Journal:  Monogr Ser World Health Organ       Date:  1973

9.  Rabies virus glycoprotein. II. Biological and serological characterization.

Authors:  J H Cox; B Dietzschold; L G Schneider
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

10.  First consequences of the determination of the entire antigenic structure of sperm-whale myoglobin.

Authors:  M Z Atassi; A L Kazim
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

View more
  24 in total

1.  Conserved nucleotide sequence of rabies virus cDNA encoding the nucleoprotein.

Authors:  K Mannen; K Hiramatsu; K Mifune; S Sakamoto
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

2.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Authors:  B Dietzschold; M Gore; D Marchadier; H S Niu; H M Bunschoten; L Otvos; W H Wunner; H C Ertl; A D Osterhaus; H Koprowski
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product.

Authors:  R Pal; B W Grinnell; R M Snyder; J R Wiener; W A Volk; R R Wagner
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

4.  Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.

Authors:  H Badrane; C Bahloul; P Perrin; N Tordo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Critical epitopes in transmissible gastroenteritis virus neutralization.

Authors:  G Jiménez; I Correa; M P Melgosa; M J Bullido; L Enjuanes
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model.

Authors:  M A Schmidt; P O'Hanley; D Lark; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Antigenicity of Japanese encephalitis virus envelope glycoprotein V3 (E) and its cyanogen bromide cleaved fragments examined by monoclonal antibodies and Western blotting.

Authors:  A K Srivastava; Y Aira; C Mori; Y Kobayashi; A Igarashi
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence.

Authors:  C Prehaud; P Coulon; F LaFay; C Thiers; A Flamand
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

9.  Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

Authors:  Milosz Faber; Rojjanaporn Pulmanausahakul; Suchita S Hodawadekar; Sergei Spitsin; James P McGettigan; Matthias J Schnell; Bernhard Dietzschold
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.

Authors:  J H Nunberg; M V Doyle; S M York; C J York
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.